Dubbing language-therapy CINEma-based in aphasia post-stroke (DULCINEA): A feasibility randomized crossover controlled trial

Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy. Randomised, crossover, interventi...

Full description

Saved in:
Bibliographic Details
Published inDigital health Vol. 10; p. 20552076241288311
Main Authors Fuentes, Blanca, Jordi-Perea, Pablo, Sempere-Iborra, Cristian, Tarifa-Rodríguez, Aida, de Celis-Ruiz, Elena, Martín Alonso, Marta, Ruiz-Ares, Gerardo, Rigual, Ricardo, Rodríguez-Pardo, Jorge, Alonso-López, Elisa, Alonso de Leciñana, María, Virués-Ortega, Javier, Borobia, Alberto M, Jiménez-González, María, Martínez-Balaguer, María, Blanco, Paloma, Bueno, Nereida
Format Journal Article
LanguageEnglish
Published United States SAGE Publications 01.01.2024
SAGE Publishing
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy. Randomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients' allocation. Recruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills. This trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored.
AbstractList Background Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. Objective We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy. Methods Randomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients’ allocation. Results Recruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills. Conclusions This trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored.
Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy. Randomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients' allocation. Recruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills. This trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored.
Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke.BackgroundHelping people recover from aphasia is among the top 10 research priorities relating to life after stroke.We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy.ObjectiveWe aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy.Randomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients' allocation.MethodsRandomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia. The intervention consisted of an individualised programme (16 sessions; 8 weeks) based on dubbing words and sentences progressively adapted to the severity of the aphasia. Patients were allocated to groups that underwent therapy within the first 3 months, or between 3 and 6 months from inclusion, each group serving as the control during the non-therapy periods. Outcomes were the pre-post differences in the Communicative Activity Log, the Boston Diagnostic Aphasia Examination, the General Health Questionnaire-12, the Stroke Aphasia Quality of Life Scale, and the Western Aphasia Battery Revised, administered by psychologists blinded to the patients' allocation.Recruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills.ResultsRecruitment was limited due to COVID-19 and prematurely stopped because of funding coming to an end. A total of 23 patients were randomised, 20 of whom completed the study (1 withdrew consent, and 2 dropped out). The adherence rate to the allocated group was 95.3%. No statistically significant differences were found in any of the outcomes; however, 17 (85%) patients reported subjective improvements in communication skills.This trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored.ConclusionsThis trial shows the feasibility of dubbing therapy (using dedicated software) for patients with post-stroke non-fluent aphasia. Although it lacks statistical power, certain effects on language and communication cannot be ignored.
Author Jordi-Perea, Pablo
Ruiz-Ares, Gerardo
Rigual, Ricardo
Fuentes, Blanca
Tarifa-Rodríguez, Aida
Borobia, Alberto M
Sempere-Iborra, Cristian
Alonso-López, Elisa
Jiménez-González, María
Bueno, Nereida
Martín Alonso, Marta
Virués-Ortega, Javier
de Celis-Ruiz, Elena
Alonso de Leciñana, María
Blanco, Paloma
Martínez-Balaguer, María
Rodríguez-Pardo, Jorge
AuthorAffiliation 2 Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
6 Asociación Afasia Activa, Madrid, Spain
5 Clinical Trials Unit. Department of Clinical Pharmacology, 16268 La Paz University Hospital , IdiPAZ Institute for Health Research, Madrid, Spain
1 Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
3 Department of Psychology, The University of Auckland, Auckland, New Zealand
4 Speech and Language Unit. Department of Rehabilitation, 16268 La Paz University Hospital , Madrid, Spain
7 Department of Psychology, 16768 Universidad Pontificia Comillas , Madrid, Spain
AuthorAffiliation_xml – name: 7 Department of Psychology, 16768 Universidad Pontificia Comillas , Madrid, Spain
– name: 1 Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– name: 3 Department of Psychology, The University of Auckland, Auckland, New Zealand
– name: 4 Speech and Language Unit. Department of Rehabilitation, 16268 La Paz University Hospital , Madrid, Spain
– name: 2 Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– name: 5 Clinical Trials Unit. Department of Clinical Pharmacology, 16268 La Paz University Hospital , IdiPAZ Institute for Health Research, Madrid, Spain
– name: 6 Asociación Afasia Activa, Madrid, Spain
Author_xml – sequence: 1
  givenname: Blanca
  orcidid: 0000-0002-0363-862X
  surname: Fuentes
  fullname: Fuentes, Blanca
  organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 2
  givenname: Pablo
  surname: Jordi-Perea
  fullname: Jordi-Perea, Pablo
  organization: Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 3
  givenname: Cristian
  surname: Sempere-Iborra
  fullname: Sempere-Iborra, Cristian
  organization: Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 4
  givenname: Aida
  surname: Tarifa-Rodríguez
  fullname: Tarifa-Rodríguez, Aida
  organization: Department of Psychology, The University of Auckland, Auckland, New Zealand
– sequence: 5
  givenname: Elena
  surname: de Celis-Ruiz
  fullname: de Celis-Ruiz, Elena
  organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 6
  givenname: Marta
  surname: Martín Alonso
  fullname: Martín Alonso, Marta
  organization: Speech and Language Unit. Department of Rehabilitation, La Paz University Hospital, Madrid, Spain
– sequence: 7
  givenname: Gerardo
  surname: Ruiz-Ares
  fullname: Ruiz-Ares, Gerardo
  organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 8
  givenname: Ricardo
  surname: Rigual
  fullname: Rigual, Ricardo
  organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 9
  givenname: Jorge
  surname: Rodríguez-Pardo
  fullname: Rodríguez-Pardo, Jorge
  organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 10
  givenname: Elisa
  surname: Alonso-López
  fullname: Alonso-López, Elisa
  organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 11
  givenname: María
  orcidid: 0000-0002-4302-6580
  surname: Alonso de Leciñana
  fullname: Alonso de Leciñana, María
  organization: Department of Neurology and Stroke Centre, La Paz University Hospital, Department of Medicine, Universidad Autónoma de Madrid, Neurosciences Area, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 12
  givenname: Javier
  surname: Virués-Ortega
  fullname: Virués-Ortega, Javier
  organization: Department of Psychology, The University of Auckland, Auckland, New Zealand
– sequence: 13
  givenname: Alberto M
  surname: Borobia
  fullname: Borobia, Alberto M
  organization: Clinical Trials Unit. Department of Clinical Pharmacology, La Paz University Hospital, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 14
  givenname: María
  surname: Jiménez-González
  fullname: Jiménez-González, María
  organization: Clinical Trials Unit. Department of Clinical Pharmacology, La Paz University Hospital, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 15
  givenname: María
  surname: Martínez-Balaguer
  fullname: Martínez-Balaguer, María
  organization: Clinical Trials Unit. Department of Clinical Pharmacology, La Paz University Hospital, IdiPAZ Institute for Health Research, Madrid, Spain
– sequence: 16
  givenname: Paloma
  surname: Blanco
  fullname: Blanco, Paloma
  organization: Asociación Afasia Activa, Madrid, Spain
– sequence: 17
  givenname: Nereida
  surname: Bueno
  fullname: Bueno, Nereida
  organization: Department of Psychology, Universidad Pontificia Comillas, Madrid, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39421311$$D View this record in MEDLINE/PubMed
BookMark eNplks1u1DAUhS1UREvpA7BBWbaLFP9lbLNBo2mBkUawoWvr2nEyLkkc7KTSIB4eT6etWrGydXzOd23f-xYdDWFwCL0n-JIQIT5SXFUUiwXlhErJCHmFTvZauRePnu2P0VlKtxhjIphQZPEGHTPFKcmRE_T3ajbGD23RwdDO0Lpy2roI465Yrb9f91AaSK4u_FDAuIXkoRhDmso0xfDLFedXN5u9b3nxqVgWjcsG4zs_7YoIQx16_ydnbQwphTsXCxuGnOu6LE7RQ_cOvW6gS-7sYT1FN1-uf66-lZsfX9er5aa0jMuptAaIMJVZMFxRSTCRtcXGkKZulDUVKFfzWgrVKKpqjsEoC5Y5To2rWCUFO0XrA7cOcKvH6HuIOx3A63shxFZDnLztnLaOWmyxBCMZr4gAJh1rgNYNZVZIyKzPB9Y4m97V1uUnQfcC-vJk8FvdhjtNCJdMUpUJ5w-EGH7PLk2698m6LnfAhTnp3BehlJScZys5WO__MLrmqQ7Bej8F-r8pyJkPzy_4lHjsOfsH_hawMQ
Cites_doi 10.1177/17474930211065917
10.1016/j.apmr.2016.03.006
10.1177/1073858413513502
10.3389/fnins.2024.1347614
10.1002/hsr2.1482
10.1177/17474930221097477
10.1080/02687038.2020.1852003
10.3758/BF03193857
10.1177/17474930231161454
10.1177/0269215518791004
10.1177/02692155221131241
10.1037/neu0000396
10.3389/fnhum.2014.00727
10.1044/jshd.2802.191
10.1901/jaba.1989.22-157
10.1093/brain/aws301
10.15252/embr.202154000
10.3389/fnhum.2013.00749
10.1093/applin/aml048
10.1186/1755-7682-6-41
10.1161/STROKEAHA.120.031162
10.1186/s13063-021-05956-5
10.1016/S1474-4422(19)30192-9
10.1080/02687031003798254
10.1007/s00221-023-06743-1
10.3109/09638288.2010.488712
10.1371/journal.pone.0174065
10.1080/02687030701612213
10.3389/fnhum.2014.00246
10.1177/1747493018806200
10.3389/fpsyg.2015.01665
10.1037/0278-7393.16.6.1084
10.1191/026921598672167702
10.7326/0003-4819-152-11-201006010-00232
10.1111/j.1747-4949.2012.00942.x
10.7326/0003-4819-158-3-201302050-00583
ContentType Journal Article
Copyright The Author(s) 2024.
The Author(s) 2024 2024 SAGE Publications Ltd, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
Copyright_xml – notice: The Author(s) 2024.
– notice: The Author(s) 2024 2024 SAGE Publications Ltd, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1177/20552076241288311
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2055-2076
ExternalDocumentID oai_doaj_org_article_ce2c0c08ab834517a38e3fa2df23c78a
10_1177_20552076241288311
39421311
Genre Journal Article
GrantInformation_xml – fundername: ;
  grantid: RD21/0006/0012
– fundername: ;
  grantid: LCF/PR/HR19/52160009
GroupedDBID 0R~
31X
53G
54M
5VS
7X7
8FI
8FJ
AAJPV
AAJQC
AANEX
AATBZ
ABAFQ
ABAWP
ABNCE
ABQXT
ABUWG
ABVFX
ABXGC
ACARO
ACGFS
ACGZU
ACROE
ACSIQ
ADBBV
ADOGD
AEFTW
AEUHG
AEUIJ
AEWDL
AEWHI
AFCOW
AFKRA
AFKRG
AFRWT
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AUTPY
AYAKG
BAWUL
BCNDV
BDDNI
BDZRT
BENPR
BMVBW
BPHCQ
BSEHC
BVXVI
CCPQU
DC.
DF.
DIK
DV7
EBS
EJD
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HMCUK
HYE
J8X
K.F
KQ8
M~E
NPM
O9-
OK1
PIMPY
PQQKQ
Q7P
ROL
RPM
SFC
SFH
SFK
SFT
SGV
SPP
UKHRP
Y4B
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c348t-cba17b5b6305281018dc0bb1fdf9cb5a9ed4d879f929d40ab9cac3e42be535873
IEDL.DBID RPM
ISSN 2055-2076
IngestDate Mon Oct 21 19:39:30 EDT 2024
Fri Oct 18 05:24:48 EDT 2024
Sat Oct 19 17:15:51 EDT 2024
Wed Oct 16 15:13:23 EDT 2024
Sat Nov 02 12:04:55 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords feasibility
aphasia
Stroke < Disease
software
randomised clinical trial
Language English
License The Author(s) 2024.
This article is distributed under the terms of the Creative Commons Attribution-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits any use, reproduction and distribution of the work as published without adaptation or alteration, provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c348t-cba17b5b6305281018dc0bb1fdf9cb5a9ed4d879f929d40ab9cac3e42be535873
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors share principal investigator responsibilities.
ORCID 0000-0002-0363-862X
0000-0002-4302-6580
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11483829/
PMID 39421311
PQID 3117998844
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_ce2c0c08ab834517a38e3fa2df23c78a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11483829
proquest_miscellaneous_3117998844
crossref_primary_10_1177_20552076241288311
pubmed_primary_39421311
PublicationCentury 2000
PublicationDate 2024-01-01
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Sage UK: London, England
PublicationTitle Digital health
PublicationTitleAlternate Digit Health
PublicationYear 2024
Publisher SAGE Publications
SAGE Publishing
Publisher_xml – name: SAGE Publications
– name: SAGE Publishing
References Vaezipour A (bibr44-20552076241288311) 2020; 8
bibr39-20552076241288311
bibr13-20552076241288311
bibr23-20552076241288311
bibr16-20552076241288311
R Core Team (bibr29-20552076241288311) 2018
bibr19-20552076241288311
bibr36-20552076241288311
bibr31-20552076241288311
Rocha KB (bibr24-20552076241288311) 2011; 11
bibr41-20552076241288311
bibr18-20552076241288311
bibr21-20552076241288311
bibr11-20552076241288311
bibr15-20552076241288311
bibr5-20552076241288311
Eldridge SM (bibr17-20552076241288311) 2016; 355
bibr2-20552076241288311
bibr12-20552076241288311
Brady MC (bibr35-20552076241288311) 2022; 29
bibr8-20552076241288311
García-Albea J (bibr20-20552076241288311) 1986
bibr45-20552076241288311
bibr28-20552076241288311
bibr38-20552076241288311
bibr42-20552076241288311
Brady MC (bibr7-20552076241288311) 2016; 2016
bibr22-20552076241288311
bibr32-20552076241288311
Sanchez-Lopez M (bibr25-20552076241288311) 2008; 20
bibr1-20552076241288311
bibr27-20552076241288311
bibr4-20552076241288311
bibr37-20552076241288311
bibr14-20552076241288311
bibr34-20552076241288311
bibr40-20552076241288311
bibr43-20552076241288311
bibr9-20552076241288311
bibr6-20552076241288311
bibr33-20552076241288311
bibr3-20552076241288311
Lata-Caneda MC (bibr26-20552076241288311) 2009; 45
bibr30-20552076241288311
bibr10-20552076241288311
References_xml – ident: bibr1-20552076241288311
  doi: 10.1177/17474930211065917
– ident: bibr2-20552076241288311
  doi: 10.1016/j.apmr.2016.03.006
– ident: bibr13-20552076241288311
  doi: 10.1177/1073858413513502
– ident: bibr38-20552076241288311
  doi: 10.3389/fnins.2024.1347614
– ident: bibr32-20552076241288311
  doi: 10.1002/hsr2.1482
– ident: bibr34-20552076241288311
  doi: 10.1177/17474930221097477
– ident: bibr3-20552076241288311
  doi: 10.1080/02687038.2020.1852003
– volume: 2016
  start-page: 1
  year: 2016
  ident: bibr7-20552076241288311
  publication-title: Cochrane Database Syst Rev
  contributor:
    fullname: Brady MC
– ident: bibr37-20552076241288311
  doi: 10.3758/BF03193857
– ident: bibr6-20552076241288311
  doi: 10.1177/17474930231161454
– ident: bibr28-20552076241288311
  doi: 10.1177/0269215518791004
– ident: bibr43-20552076241288311
  doi: 10.1177/02692155221131241
– volume: 355
  start-page: 1
  year: 2016
  ident: bibr17-20552076241288311
  publication-title: BMJ (Online)
  contributor:
    fullname: Eldridge SM
– ident: bibr41-20552076241288311
  doi: 10.1037/neu0000396
– volume-title: A language and environment for statistical computing
  year: 2018
  ident: bibr29-20552076241288311
  contributor:
    fullname: R Core Team
– ident: bibr12-20552076241288311
  doi: 10.3389/fnhum.2014.00727
– ident: bibr8-20552076241288311
  doi: 10.1044/jshd.2802.191
– ident: bibr42-20552076241288311
  doi: 10.1901/jaba.1989.22-157
– ident: bibr10-20552076241288311
  doi: 10.1093/brain/aws301
– ident: bibr45-20552076241288311
  doi: 10.15252/embr.202154000
– ident: bibr11-20552076241288311
  doi: 10.3389/fnhum.2013.00749
– ident: bibr16-20552076241288311
  doi: 10.1093/applin/aml048
– ident: bibr40-20552076241288311
  doi: 10.1186/1755-7682-6-41
– ident: bibr33-20552076241288311
  doi: 10.1161/STROKEAHA.120.031162
– volume: 8
  year: 2020
  ident: bibr44-20552076241288311
  publication-title: JMIR Mhealth Uhealth
  contributor:
    fullname: Vaezipour A
– volume: 29
  start-page: 956
  year: 2022
  ident: bibr35-20552076241288311
  publication-title: Stroke
  contributor:
    fullname: Brady MC
– ident: bibr19-20552076241288311
  doi: 10.1186/s13063-021-05956-5
– ident: bibr31-20552076241288311
  doi: 10.1016/S1474-4422(19)30192-9
– ident: bibr9-20552076241288311
  doi: 10.1080/02687031003798254
– ident: bibr21-20552076241288311
  doi: 10.1007/s00221-023-06743-1
– ident: bibr4-20552076241288311
  doi: 10.3109/09638288.2010.488712
– volume: 45
  start-page: 379
  year: 2009
  ident: bibr26-20552076241288311
  publication-title: Eur J Phys Rehabil Med
  contributor:
    fullname: Lata-Caneda MC
– volume: 11
  start-page: 125
  year: 2011
  ident: bibr24-20552076241288311
  publication-title: Int J Clin Health Psychol
  contributor:
    fullname: Rocha KB
– ident: bibr36-20552076241288311
  doi: 10.1371/journal.pone.0174065
– start-page: 129
  volume-title: La evaluación de la afasia y de trastornos relacionados
  year: 1986
  ident: bibr20-20552076241288311
  contributor:
    fullname: García-Albea J
– ident: bibr22-20552076241288311
  doi: 10.1080/02687030701612213
– ident: bibr14-20552076241288311
  doi: 10.3389/fnhum.2014.00246
– ident: bibr23-20552076241288311
  doi: 10.1177/1747493018806200
– ident: bibr39-20552076241288311
  doi: 10.3389/fpsyg.2015.01665
– ident: bibr15-20552076241288311
  doi: 10.1037/0278-7393.16.6.1084
– ident: bibr27-20552076241288311
  doi: 10.1191/026921598672167702
– ident: bibr30-20552076241288311
  doi: 10.7326/0003-4819-152-11-201006010-00232
– ident: bibr5-20552076241288311
  doi: 10.1111/j.1747-4949.2012.00942.x
– ident: bibr18-20552076241288311
  doi: 10.7326/0003-4819-158-3-201302050-00583
– volume: 20
  start-page: 839
  year: 2008
  ident: bibr25-20552076241288311
  publication-title: Psicothema
  contributor:
    fullname: Sanchez-Lopez M
SSID ssj0001737916
Score 2.2901073
Snippet Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. We aimed to evaluate the feasibility of dubbing...
Background Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke. Objective We aimed to evaluate the...
Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke.BackgroundHelping people recover from aphasia is...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 20552076241288311
SubjectTerms Original
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHhAXxJvykpE4AFJEbI9rm1vZhxbE7olKe4v8ZCvYpNqmh0X8eMZOumoBiQvXxEkmnrHmm_H4G0JeSc185CFn7q2oIALgmlNQJQPWuAAm6nze-eR0ejyHT2fybKvVV64JG-iBh4l7h2_yta-1dVqAZMoKHUWyPCQuvNIDNKrNVjBVsitKKAQ-4zZmZljitZQcg3b0WLnBLmM7jqjw9f8NZP5eK7nlfI7ukNsjaqSzQdq75EZs75GbJ-O--H3y82DtMMT9Sjfpx2o4V3VF9z-eHl7YKjurQBcttcvzfG6SLrtVX636y-5bpK8P5p_zuNmb93RGU7RjyewVRUcWuovFD3y2_EWu96Rjdft3vFh6fjwg86PDL_vH1dhXofICdF95Z5ly0k1xrfNM8KWDr51jKSTjnbQmBghamYTQKUBtnfHWiwjcRSmkVuIh2Wu7Nj4mFJRK6AZ1mEoLIVonjPcYciedfJwKNiFvN5PcLAf6jIaNDON_aGRCPmQ1XA_MzNflAtpDM9pD8y97mJCXGyU2uFLy9odtY7deNaKw32kNMCGPBqVef0oY4KyIoHfUvSPL7p12cV7YuHNAKTQ3T_6H9E_JLY6oacjxPCN7_eU6PkfU07sXxcB_AVjTAPU
  priority: 102
  providerName: Directory of Open Access Journals
Title Dubbing language-therapy CINEma-based in aphasia post-stroke (DULCINEA): A feasibility randomized crossover controlled trial
URI https://www.ncbi.nlm.nih.gov/pubmed/39421311
https://www.proquest.com/docview/3117998844
https://pubmed.ncbi.nlm.nih.gov/PMC11483829
https://doaj.org/article/ce2c0c08ab834517a38e3fa2df23c78a
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa2ISFeEPd1g8pIPABS1sSX2Oat6zoNRKsJUalvka9bxZpUbfowxI_HdpJpBZ54dWzFyTnW-c7tMwDvKM-0RSZE7iVOiCXEnzlGEieIFMoQYXnod55M84sZ-TKn8z2Qd70wsWhfq8VJebM8KRfXsbZytdSDrk5scDkZBQyPORKDfbDvNfSejx4jKwwzD3raFGZgV0Ippcg77N5ahct1s2zHCEWu_n8BzD_rJO8ZnvMn4HGLGOGw2dlTsGfLZ-DhpM2JPwe_zrbKu7dXsAs9Jk1P1S0cfZ6OlzIJhsrARQnl6jr0TMJVtamTTb2uflj4_mz2NcwbfvgEh9BZ2ZbL3kJvxEy1XPz0a-NXhFpP2Fa23_jBeN_HCzA7H38fXSTtnQqJxoTXiVYyY4qq3J9zFMi9uNGpUpkzTmhFpbCGGM6E87DJkFQqoaXGliBlKaac4ZfgoKxKewggYcx5E8hNTiUxViostPbutuNO2xxnPfCx-8nFqqHOKLKWXfwvifTAaRDD3cTAeh0HqvVV0cq-8FqlU51yqTgmNGMSc4udRMYhrBmXPfC2E2LhT0lIfcjSVttNgSPzHeeE9MCrRqh3r8KCoCxuge-Ie2cvu0-8YkYm7k4Rj_5_6TF4hDxOaqI6r8FBvd7aNx7n1KrvlXvO-uDB6Xh6-a0fowX9qOq_AdBmAtQ
link.rule.ids 230,315,730,783,787,867,888,2109,27936,27937,31732,33757,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZKkYAL70d4GokDIG2y60dscwtpqxSSiEMjelv52UZtdqNkc2jFj8f27lZN4QJXP7TenZmd8fibzwB8oDzTFpmQuZc4IZYQb3OMJE4QKZQhwvJQ7zyZ9kcz8u2YHu-AflsLE0H7Ws27xfmiW8xPI7ZyudC9FifW-zEZhhgecyR6t8Btb7ApubZLj7kVhpkPe5pDzMCvhFJKkd-ye38VrtfNsi03FNn6_xZi3kRKXnM9Bw_Az3bRNeLkrLupVFdf3uBz_Pe3egjuN9EoHNT9j8COLR6DO5PmvP0J-LW3UX7rfALbtGZS12tdwOHhdH8hk-AEDZwXUC5PQz0mXJbrKllXq_LMwo97s3EYN_j0BQ6gs7KB4l5A7yBNuZhf-rnx-wQcKWxQ8-e-Md4l8hTMDvaPhqOkua8h0ZjwKtFKZkxR1ff_EBSIw7jRqVKZM05oRaWwhhjOhPMhmSGpVEJLjS1BylJMOcPPwG5RFvYFgIQx590rN30qibFSYaG138o77rTt46wDPrfiy5c1LUeeNczlf8i6A74GAV8NDIzasaFcneSNBHKvsTrVKZeKY0IzJjG32ElkHMKacdkB71v1yL0FhmMVWdhys85xZNXjnJAOeF6ry9WjsCAoi0vgW4q0tZbtHq8ekeW7VYeX_z_1Hbg7OpqM8_Hh9PsrcA_5eKzOHr0Gu9VqY9_4eKpSb6Px_AZtPSGJ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Lb9MwGLdgSBMX3ozyNBIHQEqbxHZicyvtqg3WagcqTeIQ-blVW5OoTQ-b-OOxHWdaB6ddHVtx_H1fvod__hmAT4QmUqfKVe45irDG2NpcjiPDMGdCYaapO-88nWUHc_zjhJwEVOU6wCpLKRb98mLZLxdnHltZL-Wgw4kNjqcjF8MjmrJBrczgPnhgjTbObmTqvr6So9yGPmEj03EspTEhqU3brc9yV-wmyZYr8oz9_wszb6Mlb7ifyWPwu5t4izo5728a0ZdXtzgd7_ZlT8CjEJXCYdvnKbiny2dgdxr23Z-DP-ONsCn0KezKm1F7busSjg5n-0seOWeo4KKEvD5z5zJhXa2baN2sqnMNP4_nR67f8Ms3OIRG8wDJvYTWUapqubiyY_0aOTwpDOj5C9vo7xR5AeaT_V-jgyjc2xBJhGkTScGTXBCR2X9J6gjEqJKxEIlRhklBONMKK5ozY0MzhWMumOQSaZwKTRChOXoJdsqq1K8AxHlurJulKiMcK80FYlLalN5QI3WGkh742omwqFt6jiIJDOb_yLsHvjshX3d0zNq-oVqdFkEKhdVcGcuYckERJknOEdXI8FSZFMmc8h742KlIYS3Rba_wUlebdYE8ux6lGPfAXqsy169CDKeJnwLdUqatuWw_sSri2b47lXh996EfwO7xeFIcHc5-vgEPUxuWtUWkt2CnWW30OxtWNeK9t5-_bxIkCQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dubbing+language-therapy+CINEma-based+in+aphasia+post-stroke+%28DULCINEA%29%3A+A+feasibility+randomized+crossover+controlled+trial&rft.jtitle=Digital+health&rft.au=Fuentes%2C+Blanca&rft.au=Jordi-Perea%2C+Pablo&rft.au=Sempere-Iborra%2C+Cristian&rft.au=Tarifa-Rodr%C3%ADguez%2C+Aida&rft.date=2024-01-01&rft.issn=2055-2076&rft.eissn=2055-2076&rft.volume=10&rft_id=info:doi/10.1177%2F20552076241288311&rft.externalDBID=n%2Fa&rft.externalDocID=10_1177_20552076241288311
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2055-2076&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2055-2076&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2055-2076&client=summon